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Abstract
Purpose: The present study aimed to determine the influence of orofacial pain in superficial 
and deep tissue on anxiety levels in male Wistar rats. 
Methods: Orofacial pain was induced by injecting 50 µL of 1% formalin in the lip (superficial 
tissue) and in the temporomandibular joint (TMJ) (deep tissue) of male Wistar rats. The anxiety 
level was measured by the elevated plus maze (EPM) test. The standard measures (number of 
entries into open and enclosed arms, and time spent in opened ones), were recorded. The 
three measures of plus-maze behavior calculated were the percentage of entries into the open   
arms (% EOA) (100 X open/total), the percentage of time spent in the open arms (% TSOA) 
(100 X open/total) and the number of entries into the closed arms (NECA). Data were analyzed 
with ANOVA and Tukey’s tests.
Results: The formalin injection in the lip and in the TMJ region significantly increased the anxiety 
level as measured by the percentage of time spent inside and the number of entries in the 
open arms of the EPM test, but did not increase the general activity measured by the number 
of entrances in the closed and opened arms. Anxiety response was significantly reduced by 
Diazepam® administration (1 mg/kg) before the formalin injection to lip/TMJ. 
Conclusion: The results suggest that the orofacial nociceptive response induced by the injection 
of 1% formalin in the lip or TMJ region increases the anxiety level in rats and that Diazepam® 
can reduce it.
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Resumo
Objetivo: Este estudo objetivou determinar a influência da dor orofacial, em tecidos superficiais 
e profundos, sobre o nível de ansiedade em ratos machos Wistar. 
Metodologia: A dor orofacial foi induzida pela injeção de 50 µL formalina a 1%, na região 
de lábio (tecido superficial) e da articulação temporomandibular (ATM) (tecido profundo)   
de ratos machos Wistar. A ansiedade foi medida utilizando o teste do labirinto em cruz 
elevado (LCE). 
Resultados: Os resultados demonstraram que as injeções de formalina no lábio e na ATM 
aumentaram significativamente o nível de ansiedade, medido pela porcentagem de tempo 
gasto nos braços abertos e pela porcentagem de entrada nos braços abertos do LCE, mas   
não aumentou a atividade geral medida pelo número de entradas nos braços abertos e 
fechados do LCE. A ansiedade foi significantemente reduzida pela administração de Diazepam® 
(1 mg/kg), previamente à injeção de formalina no lábio e na ATM. 
Conclusão: Os resultados sugerem que a dor orofacial induzida pela injeção de formalina 
1% na região do lábio e da ATM é capaz de aumentar o nível de ansiedade em ratos e que 
a administração de Diazepam® pode reduzir esta resposta.
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Introduction
Previous  studies  have  shown  an  association  between 
psychological  changes  and  temporomandibular  joint 
dysfunction  (TMD)  (1,2).  It  has  been  estimated  that 
approximately 20% to 30% of the adult population will 
experience TMD in their lifetime (3), and pain associated 
with TMD may occur in about 70% of patients diagnosed 
with these disorders (4).  
Pain is an unpleasant experience that reflects on interpersonal 
relationship. It is considered an aversive stimulus able to 
alter the patient’s level of anxiety. Anxiety is an emotional 
state subjectively considered unpleasant or threatening, 
including symptoms such as alterations in the mood and 
cognition, mostly followed by behavioral and physiological 
changes, such as palpitation, and sudoresis (5). Anxiety 
can become pathological when a response to the stimulus 
becomes exaggerated and irritating interfering in the quality 
of life (5). Considering that thoughts and feelings related to 
pain suffering may play an important role in dental distress 
similarly to the pain in other parts of the body, anxiety is 
probably the most important of the non-sensory components 
of dental pain (2). In the last years different studies have 
analyzed the possible role of anxiety in pain responses (1), 
but the influence of pain, mainly orofacial pain, on anxiety 
levels is still unknown.
To  measure  pain  and  anxiety  in  human  beings  is  very 
complex.  Animal  models  may  help  to  investigate  the 
mechanisms involved in normal and pathological behavior. 
The formalin (FT) and the elevated plus-maze (EPM) tests 
are useful tools to study pain and anxiety, respectively. 
The FT is widely used as a model for subacute tissue injury-
induced pain in rodents (6). The formalin injection into the 
paw elicits a biphasic behavioral response in rats (7,8). This 
test is considered a model of inflammatory tonic pain and 
it is sensitive to many classes of analgesic drugs (9). An 
adaptation of this test for assessing pain and analgesia in the 
orofacial region of the rat was introduced by Clavelou et al. 
(1995) (10). The formalin injection in the upper lip induced a 
nociceptive behavioral response in the animal characterized 
by rubbing the formalin-injected upper lip whit the ipsilateral 
fore or hindpaw. In 2001, Roveroni et al. (11) developed a 
behavioral model of orofacial pain in deep tissues of rats 
using formalin injection in the TMJ region. The formalin 
administration in the TMJ causes behavioral responses in 
rats characterized by moving the mandible, rubbing the 
orofacial region and flinching the head quickly.
The elevated plus maze test is one of the most widely used 
models in animals, in contemporary preclinical research 
on anxiolytic drugs and neurobiological mechanisms of   
anxiety (12,13). This model is based on the natural fear 
of open and elevated alleys (14). As a consequence, rats 
on the EPM tend to avoid the open arms and stay more on 
the enclosed arms.  Anxiolytic drugs increase the number 
of entries and the time spent in the open arms, whereas 
anxiogenic agents does the opposite (15). When confined 
to the open arms, rats show behavioral and physiological 
manifestations of fear, such as freezing, defecation, and 
plasma corticosteroids increasing. Different aversive stimuli 
are able to alter the animal’s anxiety level (12). Pain is 
also considered an aversive stimulus that generates many 
behavioral alterations. 
Therefore, the present investigation explores the possibility 
of orofacial pain, in superficial (in lip) as well as in deep 
(in TMJ) tissues, to modify the anxiety level of rats and the 
administration of Diazepan® role in this process.
Methods 
Wistar male rats, “specific pathogen free” (CEMIB, University 
of Campinas – UNICAMP, Piracicaba, SP, Brazil), 3-month-
old, were used (n=10-15 per group). Groups of five animals 
were housed in plastic cages with food and water ad libitum, 
under constant conditions of temperature (22±2ºC), humidity 
and a 12:12 h light/dark cycle. The animals were not handled 
before starting the experiments. The experimental sessions 
were conducted between 7:30 and 11:30 AM. All procedures 
were approved by the Institutional Animal Care and Use 
Committee (Protocol 392-102).
The EPM test consisted of two open arms measuring 50 
X 10 cm, crossed at right angles with two opposed arms 
of the same size. The latter were enclosed by 40 cm high 
walls, except for the entrance. The four arms delimited a 
central area of 10 cm2 where the arms crossed. The whole 
apparatus was elevated 50 cm above the floor. To prevent 
the rats from falling down, a rim of Plexiglas® (1 cm high) 
was made to surround the perimeter of the open arms. The 
experimental sessions were recorded by a vertically mounted 
video camera, linked to a monitor and a VCR in an adjacent 
room. Afterwards, the videotapes were analyzed by three 
calibrated observers who were blinded to the treatment 
conditions.
The  solutions  administered  in  the  experiment  were: 
Halothane® (Cristália, São Paulo, SP, Brazil);  Diazepam® 
(Roche, Jacarepaguá, RJ, Brazil) diluted in propilenoglicol 
40% (01 mg/kg) (16); 1.0% Formalin prepared from 37% 
stock formaldehyde (Sigma-F-1635, Sigma Chemical Co®; 
St Louis, MO, USA) further diluted in 0.9% saline; Blue 
Evans 1% (Sigma Chemical Co®; St Louis, MO, USA) 
dissolved in physiological saline (30 mg/kg body weight).
On the experiment day, the animals were taken to the test 
laboratory room, at least 30 minutes before treatment, and 
anaesthetized with halothane for 40 s before any procedure. 
To evaluate the effect of superficial (lip) and deep (TMJ) 
orofacial pain on the anxiety level, the rats were randomly 
allocated to the experimental groups shown in Table 1.
Gentle aspiration ruled out any intravascular placement, 
after administration of 50 µL of the experimental solution. 
For the lip and TMJ injection a 30-gauge needle was used 
associated with a 0.5-in needle coupled to a Hamilton 
microsyringe through a polietylene canule. After the EPM 
test, the formalin/saline TMJ group received intracardiac 
injection of Evans’ blue dye to confirm if the formalin 
administration was adequate.378  Rev. odonto ciênc. 2010;25(4):376-381
Orofacial pain and anxiety level in rats
To  validate  the  behavioral  result  and  evaluate  the  γ- 
Aminobutyric acid (GABA) role in the alteration observed 
in  experiment  1,  other  experiments  were  performed 
(Table 2).
Animals  were  anesthetized  with  halothane  prior  to 
intraperitoneal drug administration, 30 min before formalin/
vehicle injection in the lip or TMJ. After treatment, the rats 
were placed in an individual cage and taken to the behavioral 
room for a 30-min waiting period before the EPM-test. For 
the behavioral test each rat was placed in the central square 
facing an enclosed arm, and allowed to freely explore the 
EPM for 5 min. The standard measures (number of entries 
into open and enclosed arms, and time spent in opened ones), 
were recorded. The three measures of plus-maze behavior 
calculated were the percentage of entries into the open arms 
(%EOA) (100 X open/total), the percentage of time spent in 
the open arms (%TSOA) (100 X open/total) and the number 
of entries into the closed arms (NECA) (12,13).
Data were statistically analyzed by using ANOVA followed 
by Tukey’s tests at the significance level of 5%. The softwares 
used for statistical calculations were Minitab, Estat and 
Sisvar (Globaltehc, Santo Agostinho, BA, Brazil).
Results
For the effect of formalin injection in the lip and in the 
TMJ region groups on anxiety levels, local factors and 
treatment of anxiety and locomotor activity in animals 
submitted to the EPM test were significant, but with no 
interaction between these two factors. For local factor, 
no statistically significant difference was found between 
anxiety and locomotor activity when formalin was injected 
in the region of TMJ or lip (P<0.05) (Table 3 and Fig. 1). 
Regarding the treatment factor, formalin 1% administration 
increased (P<0.05) anxiety level significantly as assessed 
by  the  %TSOA  and  the  %EOA  (Table  3  and  Fig.  1). 
Groups Procedures
group 1 (anesthetic control) (n=15) rats only anaesthetized by halothane
group 2 (formalin in the lip) (n=15) 50 µL formalin 1% applied in the lip16
group 3 (saline in the lip) (n=15) 50 µL saline applied in the lip16
group 4 (formalin in the TMJ) (n=12) 50 µL formalin 1% applied in periarticular area11
group 5 (saline in the TMJ) (n=15) 50 µL saline applied in periarticular area11 
Groups Procedures
group 6 (n=15) 50 µL formalin 1% applied in the lip + diazepam 
group 7 (n=12) 50 µL formalin 1% applied in the lip + vehicle 
group 8 (n=11) 50 µL formalin 1% applied in TMJ region + diazepam 
Table 1. Phase I of the experimental 
study: groups and treatments.
Table 2. Phase II of the experimental 
study: groups and treatments.
Control group 
(n=15)
Saline/Lip 
(n=15)
Formalin/Lip 
(n=15)
Saline/TMJ 
(n=15)
Formalin/TMJ 
(n=12)
%TSOA   8.22±2.69 b   8.01±1.70 b 1.46±0.68 a 4.16±1.36 b 1.05±0.48 a
%EOA 21.25±5.44 b 23.51±4.01 b 7.77±3.13 a 9.01±3.07 b 9.02±4.03 a
NECA   6.07±0.84 b   5.53±0.84 b 4.53±0.75 b 5.53±0.71 b  4.17±0.65 b
* P<0.05, means followed by different letters differ significantly.
Fig. 1. Mean (± S.E.M.) %TSOA (A), %EOA (B) and 
NEBF (C) of the control group (CG), saline lip (SL), 
formaline lip (FL), saline TMJ (STMJ and formaline 
TMJ (FTMJ) during the EPM test (P<0.05).  
Sample size is indicated in parenthesis.
Table 3. Comparison of %TSOA,   
% EOA and NECA between control 
and experimental groups submitted to 
the EPM test after injection of saline or 
formalin in the lip or TMJ. Mean   
(± standard error of the mean).  Rev. odonto ciênc. 2010;25(4):376-381  379
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As estimated by NECA, formalin did not alter the locomotor 
activity of animals tested with the LCE in comparison with 
the rats treated with saline control (Fig. 1).
The intraperitoneal administration of Diazepam® (1.0 mg/
kg body weight) significantly reduced (P<0.05) the anxiety-
induced nociception response by formalin 1% injection in 
both lip and TMJ, as seen mainly by %TSOA (Fig. 2 B). 
However, there was not effect on the locomotor activity as 
measured by % EOA% and NECA (Table 4 and Fig. 2).
Discussion
Orofacial pain and anxiety seem to be related (17). As 
the measurement of pain and anxiety in human beings 
is complex, animal models are useful to allow a better 
control of the experimental variables. The pain, similarly to 
different aversive stimuli, is able to alter the anxiety level of 
animals (15). To study orofacial pain in deep tissue many 
substances has been used such as mustard oil, glutamate, 
carrageenin and formaline (18). The FT is a reliable method 
for assessing pain in the trigeminal region (10,11,15).  
The EPM-test is an experimental model in laboratory animals 
to measure anxiety levels (12), where the percentage of 
time spent in the open arms is inversely related to anxiety 
levels (12,13). Since the measurement of anxiety may be 
influenced by locomotor activity, this factor was assessed by 
recording the absolute number of closed-arm entries, which 
is considered to be an indicator of general motor activity (12). 
The lower percentage of time spent in the open arms by the 
animals that received formalin injection in the lip or in the 
TMJ regions compared with the control indicated that pain 
increased the level of anxiety. These findings suggest that 
the anxiogenic effect, after formalin injections, was related 
with the stimulated anxiety and not to the locomotor activity 
of the rats.
For pain induction by injecting algesic agents in the rats’ 
periarticular regions, the animals were first anesthetized 
by halothane inhalation. Although pre-administration of 
halothane can reduce the paw edema induced by formalin 
injection to a limited extent, it does not produce an inhibitory 
effect on the nociceptive behavioral response shown by 
the rats that were submitted to the formalin test (14). This 
ensured that there was no interference of halothane in the 
induction of formalin nociceptive stimuli.
Whereas there was the deposition of a certain volume of 
solution in the area injected (lip or TMJ), the pressure caused 
by this volume may have been an important factor in the 
activation of local nociceptors response, likely to cause pain 
and alter the anxiety level. However, there was no statistically 
significant difference neither in the percentage of time spent 
inside or the number of entries in the open arms, or even 
in the number of entries in the closed arms of the control 
group (GC) compared with the group that received saline 
injection in the lip or TMJ area. Therefore, these findings 
suggest that the saline injection in the orofacial region did 
not change the anxiety level nor the locomotor activity of 
rats tested with the EPM.
A reduction in the percentage of time spent inside and in 
the number of entries in the open arms in the EPM test 
induced by formalin injection in the lip and in the TMJ areas, 
Table 4. Comparison of % TSOA, % EOA and NECA between control and experimental groups submitted to EPM test after injection 
of 1% formalin in the orofacial area. Mean (± standard error of the mean).
Control group 
(n=15)
Formalin/Lip 
(n=15)
Formalin/Lip/ 
Propylene (n=12)
Formalin/Lip/ 
Diazepan (n=15)
Formalin/TMJ 
(n=12)
Formalin/TMJ/ 
Diazepan (n=11)
% TSOA 8.22±2.69 b 1.46±0.68 a 0.83±0.44 a 4.11±1.68 bc 1.04±0.47 a 2.66±1.23 bc
% EOA 21.25±5.43 7.76±3.13 5.83± 2.94 15.69±5.95 9.01±4.02 7.90±3.35
NECA 6.06±0.83 4.53±0.74 4.91±0.77 3.4±0.55 4.16±0.64 5.36±0.946
* P<0.05, means followed by different letters differ significantly.
Fig. 2. Mean (± S.E.M.) %TSOA (A), %EOA (B)  
and NEBF (C) of the control group (CG), 
formaline/lip (FL), formaline/lip/propylene (FLP), 
formaline/lip/Diazepam (FLD), formaline/TMJ (FTMJ) 
and formaline/TMJ/Diazepam (FTMJD) during  
the EPM test (P<0.05). Sample size is indicated  
in parenthesis.380  Rev. odonto ciênc. 2010;25(4):376-381
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compared with their controls, indicates that this procedure 
has an anxiogenic effect. When analyzing the number of 
entries in the closed arms, there was no significant difference 
between  the  groups,  indicating  that  although  the  pain 
induced by formalin injection increases the anxiety levels, 
this procedure does not change the locomotor activity of the 
animals as previously reported by Roveroni et al. (11).
Although  there  are  differences  between  the  pain  from 
superficial and deep orofacial tissues (20), which could 
reflect changes in the anxiety levels, the results of the present 
study showed that when the lip/formalin and TMJ/formalin 
groups were compared, the percentage of time spent in the 
open arms was not different between groups. This finding 
suggests that the injection of 1% formalin in the orofacial 
region produces a nociceptive stimulus that induces anxiety 
in a similar degree, regardless of the area in which it was 
injected.  Probably,  the  mechanism  of  action  by  which 
formalin is able to alter the levels of anxiety involves the 
release of endogenous serotonin, which occurred during the 
phase 2 of the formalin test (20). 
The increase of time spent inside the open arms by the 
animals that had received formalin injection in the lip or the 
TMJ regions associated with an application of Diazepam® 
injection afterwards (Table 4) shows that the intraperitoneal 
anxiolytic administration reduced the anxiety level caused 
by the formalin injections in both areas, compared with their 
respective controls. This demonstrated that the behavioral 
changes as observed during the EPM tests are related to the 
alterations of anxiety levels as a result of the formalin treatment.
The fact that Diazepam® reduced the anxiety induced by the 
formalin injection in the orofacial region does not exclude 
the possibility that the anxiolytic could be acting directly 
on the nociceptive system, which would result in a change 
in the EPM test results. No other studies have assessed the 
antinociceptive effect of Diazepam® in the formalin test in 
the orofacial region. 
Based on these results, one accepts the hypothesis that 
nociceptive response in rats’ orofacial area induced by 1% 
formalin injection in the lip or the TMJ regions can influence 
anxiety levels. Although our results show that the formalin 
nociception-induced in the orofacial region can increase 
anxiety levels in this animal model, it is not possible to 
conclude that anxiety could interfere with nociception. 
We believe that due to the fact that there are several nerve 
pathways involved in both pain and anxiety, these two 
factors can overlap and mask the results.
Animal  models  allow  the  investigation  of  nociception 
but not of pain perception. Although the most important 
point to be examined is the perception of pain, it depends 
on a number of emotional, cultural and social factors with 
individual responses. This is why studies in humans are 
the ultimate standard to unravel the complex relationship 
between orofacial pain and anxiety. 
Considering the relation between psychological factors and 
the incidence of temporomandibular disorders, anxiety is 
the major factor of pain perception, and individuals that 
show high anxiety levels in their daily behavior are more 
reactive  to  pain  than  those  who  are  less  anxious  (21). 
However, the results of the present study showed that pain 
can also increase anxiety levels. Therefore, it is necessary 
that dentists acknowledge that orofacial pain, regardless of 
its origin, can alter patients’ levels of anxiety, consequently 
intensifying the distress and inducing a vicious cycle in 
which pain and anxiety are exacerbated, which may influence 
the outcome of any dental treatment. This ratifies the need 
for the interdisciplinary approach of a health team to treat 
orofacial pain cases. 
Conclusions
The  results  suggest  that  orofacial  nociceptive  response 
induced by 1% formaline injection in superficial (lip) and 
deep (TMJ) region of rats increases the anxiety level without 
interfering in the locomotor activity. Diazepam® reduces 
the anxiety caused by orofacial pain in both superficial and 
deep tissue.
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